logo

Sanofi U.S. Manufacturing Capacity Expansion

Sector: Manufacturing (Industrial) • Location: United States

Source: ETPharma.com

Project
Planned

Sanofi plans to invest at least $20 billion in the U.S. through 2030 to boost manufacturing and research, expanding its U.S. manufacturing capacity through direct investments and partnerships with other domestic manufacturers.

Status
Prospective
Sector
Manufacturing (Industrial)
Location
United States of America
Updated
22 Jul 2026
Source
ETPharma.com

ConstructChat

Ask ConstructChat about Sanofi U.S. Manufacturing Capacity Expansion

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Sanofi U.S. Manufacturing Capacity Expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in United States. Taiyo aggregates data on it from ETPharma.com.

Participants

Not available for this record.

Status

Original status

planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Sanofi plans to invest at least $20 billion in the U.S. through 2030 to boost manufacturing and research, expanding its U.S. manufacturing capacity through direct investments and partnerships with other domestic manufacturers.

Original sector

Pharmaceutical Manufacturing

Budget

Location

Country

United States of America (USA)

Source

Source

ETPharma.com

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial)

Article published date

2025-11-22

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project